What are the symptoms of Multisystem Inflammatory Syndrome in Children (MIS-C)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Multisystem Inflammatory Syndrome in Children (MIS-C)

The primary symptoms of MIS-C include persistent fever (≥38.0°C for ≥24 hours or ≥3 days), gastrointestinal manifestations (abdominal pain, diarrhea, vomiting), mucocutaneous findings (rash, conjunctivitis, red/cracked lips, strawberry tongue), and cardiovascular involvement often progressing to shock. 1

Core Clinical Features

Cardinal Symptoms (Present in Most Cases)

  • Fever: Present in nearly 100% of cases 2
  • Gastrointestinal symptoms (77-94% of cases):
    • Abdominal pain (most common)
    • Diarrhea
    • Vomiting 2, 3
  • Mucocutaneous manifestations (63-68% of cases):
    • Polymorphic rash (maculopapular or petechial, not vesicular)
    • Bilateral conjunctivitis (without exudate)
    • Red/cracked lips
    • Strawberry tongue
    • Erythema of oropharyngeal mucosa
    • Swollen hands and feet 1

Common Additional Symptoms

  • Headache (68%) 3
  • Lymphadenopathy (especially cervical) 1
  • Neck swelling 1
  • Sore throat 1
  • Syncope 1
  • Confusion or altered mental status 1

Organ System Involvement

Cardiovascular (Very Common)

  • Myocardial dysfunction (40-53% of cases)
  • Pericarditis (20%)
  • Coronary artery abnormalities (13%)
  • Shock (14-23% requiring intensive care) 2, 3
  • Elevated cardiac markers (troponin in 41%, NT-pro-BNP in 50%) 2

Respiratory

  • Respiratory symptoms in 28% of cases 4
  • Cough 1
  • Respiratory distress (less common than in acute COVID-19) 4

Neurological

  • Headache
  • Altered mental status
  • Encephalopathy
  • Focal neurologic deficits
  • Meningismus
  • Seizures (10.5%) 3
  • Papilledema 1

Renal

  • Acute kidney injury (26%) 3

Hematologic

  • Lymphopenia (84%)
  • Thrombocytopenia (37%) 3

Laboratory Findings

Inflammatory Markers (Markedly Elevated)

  • C-reactive protein (CRP) >10 mg/dL (often >15 mg/dL)
  • Elevated erythrocyte sedimentation rate (ESR)
  • Elevated ferritin
  • Elevated procalcitonin
  • Elevated D-dimer
  • Elevated IL-6 1

Other Laboratory Abnormalities

  • Neutrophilia
  • Lymphopenia
  • Hypoalbuminemia
  • Hyponatremia (Na <135 mmol/L)
  • Elevated liver enzymes 1

Warning Signs Requiring Immediate Medical Attention

  • Abnormal vital signs (tachycardia, tachypnea)
  • Respiratory distress of any severity
  • Neurologic deficits or changes in mental status (even subtle)
  • Evidence of renal or hepatic injury
  • Marked elevations in inflammation markers (CRP >10 mg/dL)
  • Abnormal EKG or elevated cardiac markers 1

Distinguishing Features from Kawasaki Disease

MIS-C differs from Kawasaki Disease in several important ways:

  • Affects a broader age range (median age 8-12 years vs. typically <5 years for KD)
  • More prominent gastrointestinal and neurologic symptoms
  • Higher likelihood of shock and cardiac dysfunction
  • Lower platelet counts and lymphocyte counts
  • Higher CRP levels
  • Higher incidence in children of African, Afro-Caribbean, and Hispanic descent 1

Timing and Association with COVID-19

MIS-C typically develops 2-6 weeks after SARS-CoV-2 infection, often after the acute infection has resolved 1. This temporal association is critical for diagnosis, as many patients may have negative PCR tests but positive serology for SARS-CoV-2 1.

Remember that MIS-C is a rare but serious complication of SARS-CoV-2 infection, with an estimated incidence of 0.69 per 1,000 SARS-CoV-2 infections 2. Early recognition of these symptoms and prompt medical attention are essential for reducing morbidity and mortality.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.